Posts Feed
Comments Feed

Archive for September, 2007

Bush Reiterates Threat To Veto Appropriations Bills

President Bush on Monday reiterated his threat to veto 10 of the 12 appropriations bills for fiscal year 2008, which begins on Monday, because of $22 billion in spending included for health care and other domestic programs that exceeds his request of $933 billion, USA Today reports (Leavitt, USA Today, 9/25). [click link for full article]

More: continued here

No Comments »

Employers, Health Insurers Increasingly Use Care Managers To Review Physicians’ Treatment Plans, Ensure They Conform To Evidence-Based Practices

A growing number of employers and health insurers are using care managers, or integrated health managers, who “essentially audit an employee’s health care and look for ways to both improve outcomes and save money,” the Wall Street Journal reports. According to the consulting firm Deloitte & Touche, there are more than 200 care managers in the U.S. [click link for full article]

More: continued here

No Comments »

Enzyme’s Second Messenger Contributes To Cell Overgrowth

Scientists at the University of California, San Diego (UCSD) School of Medicine have uncovered a novel pathway by which hormones elevated in inflammation, cancer and cell injury act on cells to stimulate their growth.The research team led by Joan Heller Brown, Ph.D. [click link for full article]

More: continued here

No Comments »

Study Reveals Motivations For Drink Spiking

A nationwide study into drink spiking found 43 per cent of drink spikers had added alcoholic shots or substances to beverages ‘for fun.’According to the RMIT study, respondents were also motivated to increase their chances of engaging in consensual sexual activity. [click link for full article]

More: continued here

No Comments »

European Commission Approves Pfizer’s CCR5 Inhibitor Maraviroc

Pfizer on Monday announced that the European Commission has approved its antiretroviral drug Celsentri, known generically as maraviroc, for sale and marketing in the European Union, Dow Jones/CNNMoney.com reports (Berton, Dow Jones/CNNMoney. [click link for full article]

More: continued here

No Comments »

Assessment Of Fruit And Vegetable Intake’s Impact On Colon Cancer Risk

Eating fruits and vegetables was not strongly associated with decreased colon cancer risk, according to a study published online in the Journal of the National Cancer Institute.Several studies have examined the relationship between colon cancer and fruit and vegetable intake, but the results have been inconsistent. A team of researchers led by Anita Koushik, Ph.D. [click link for full article]

More: continued here

No Comments »

Breast Cancer Death Rate Continues Downward Trend

A report from the American Cancer Society finds the breast cancer death rate in the United States continues to drop more than two percent per year, a trend that began in 1990 and is credited to progress in early detection and treatment. [click link for full article]

More: continued here

No Comments »

Genzyme And Bayer Schering Pharma AG, Germany Announce Start Of Phase 3 Program With Alemtuzumab For Treatment Of Multiple Sclerosis

Genzyme Corporation (Nasdaq: GENZ) and Bayer Schering Pharma AG, Germany announced that the first patient has been treated in the first of two planned Phase 3 trials examining the safety and efficacy of alemtuzumab for the treatment of multiple sclerosis (MS). [click link for full article]

More: continued here

No Comments »

CDC Study Links Thimerosal In Vaccines To Motor/Phonic Tics And Deficits In Attention, Behavior Control, Verbal IQ

The National Autism Association (NAA) says that a CDC study of only 1047 participants, low compliance rate, and very little data variation — limitations that would ordinarily bar publication in any reputable journal — appears to misinform the public. They question how such a poor quality study and misleading conclusion can be published in the New England Journal of Medicine (NEJM). [click link for full article]

More: continued here

No Comments »

Oral Drug Candidate for theTtreatment of Pneumocystis Pneumonia - Chinese SFDA Grants Immtech Fast Track Status

Immtech Pharmaceuticals, Inc. (Immtech) (Amex: IMM) announced that the State Food and Drug Administration of the People’s Republic of China (SFDA) has granted Immtech’s application Fast Track Status for conducting a Phase III clinical trial with pafuramidine, the Company’s oral drug candidate for the treatment of Pneumocystis pneumonia (PCP). [click link for full article]

More: continued here

No Comments »

« Prev - Next »

1